Merit Medical Systems (MMSI) – Research Analysts’ Recent Ratings Updates

Several analysts have recently updated their ratings and price targets for Merit Medical Systems (NASDAQ: MMSI):

• 2/26/2025 – Merit Medical Systems had its price target lowered by analysts at Wells Fargo & Company from $120.00 to $117.00. They now have an “overweight” rating on the stock.
• 2/26/2025 – Merit Medical Systems had its price target lowered by analysts at Barrington Research from $115.00 to $111.00. They now have an “outperform” rating on the stock.
• 2/26/2025 – Merit Medical Systems had its price target lowered by analysts at Canaccord Genuity Group Inc. from $128.00 to $127.00. They now have a “buy” rating on the stock.
• 2/26/2025 – Merit Medical Systems had its price target lowered by analysts at Needham & Company LLC from $122.00 to $116.00. They now have a “buy” rating on the stock.
• 1/29/2025 – Merit Medical Systems had its “overweight” rating reaffirmed by analysts at Piper Sandler. They now have a $116.00 price target on the stock, up previously from $114.00.
• 1/29/2025 – Merit Medical Systems had its price target raised by analysts at Barrington Research from $114.00 to $115.00. They now have an “outperform” rating on the stock.
• 1/29/2025 – Merit Medical Systems had its price target raised by analysts at Needham & Company LLC from $109.00 to $122.00. They now have a “buy” rating on the stock.
• 1/29/2025 – Merit Medical Systems had its price target raised by analysts at Canaccord Genuity Group Inc. from $127.00 to $128.00. They now have a “buy” rating on the stock.
• 1/21/2025 – Merit Medical Systems had its price target raised by analysts at Piper Sandler from $110.00 to $114.00. They now have an “overweight” rating on the stock.
• 1/14/2025 – Merit Medical Systems had its “buy” rating reaffirmed by analysts at Needham & Company LLC. They now have a $109.00 price target on the stock.

Merit Medical Systems Stock Performance

Shares of MMSI traded down $0.03 during trading hours on Wednesday, reaching $98.37. 377,782 shares of the company traded hands, compared to its average volume of 585,851. The company has a debt-to-equity ratio of 0.57, a quick ratio of 3.82 and a current ratio of 5.36. The stock’s fifty day moving average is $103.39 and its 200 day moving average is $100.56. Merit Medical Systems, Inc. has a 1-year low of $70.70 and a 1-year high of $111.45. The stock has a market cap of $5.79 billion, a P/E ratio of 48.22, a price-to-earnings-growth ratio of 2.34 and a beta of 0.91.

Insiders Place Their Bets

In related news, Director Stephen C. Evans sold 5,000 shares of the firm’s stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $105.31, for a total value of $526,550.00. Following the completion of the transaction, the director now directly owns 4,657 shares of the company’s stock, valued at $490,428.67. This trade represents a 51.78 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Brian G. Lloyd sold 30,000 shares of the business’s stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $102.90, for a total transaction of $3,087,000.00. Following the completion of the sale, the insider now directly owns 38,945 shares in the company, valued at $4,007,440.50. This trade represents a 43.51 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 109,132 shares of company stock worth $11,139,521. 3.70% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in MMSI. Norges Bank acquired a new position in shares of Merit Medical Systems in the 4th quarter worth approximately $66,638,000. FMR LLC grew its position in Merit Medical Systems by 70.1% in the third quarter. FMR LLC now owns 1,577,246 shares of the medical instruments supplier’s stock valued at $155,879,000 after acquiring an additional 649,799 shares during the period. Raymond James Financial Inc. acquired a new position in Merit Medical Systems during the fourth quarter worth $48,926,000. Groupama Asset Managment bought a new position in shares of Merit Medical Systems during the fourth quarter valued at $38,688,000. Finally, Bryn Mawr Capital Management LLC acquired a new stake in shares of Merit Medical Systems in the 4th quarter valued at $36,057,000. Institutional investors and hedge funds own 99.66% of the company’s stock.

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.